107 results
Page 3 of 6
S-4
EX-10.37
xq626
16 Jun 20
Registration of securities issued in business combination transactions
5:11pm
S-4
EX-10.40
kuqzc6 gp4k3m406
16 Jun 20
Registration of securities issued in business combination transactions
5:11pm
S-4
EX-10.39
qvrj1s h5lgeos1tn
16 Jun 20
Registration of securities issued in business combination transactions
5:11pm
8-K
EX-10.1
g5llu0g32n911o16b4
10 Jun 20
DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline
8:50am
8-K
EX-10.2
ymwu9go
10 Jun 20
DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline
8:50am
425
EX-10.2
onobqq
10 Jun 20
Business combination disclosure
8:48am
425
EX-10.1
ji3j34gzx 6p4w9
10 Jun 20
Business combination disclosure
8:48am
8-K
EX-10.1
vwai5jc 44yx
9 Sep 19
Departure of Directors or Certain Officers
4:23pm
8-K/A
EX-10.1
14iqim
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am
8-K/A
EX-10.2
tov9hqq4pres9h
3 Jun 19
Financial Statements and Exhibits
5:11pm
8-K/A
EX-10.1
hakz1
3 Jun 19
Financial Statements and Exhibits
5:11pm
8-K
EX-10.1
970ugm5pyf7e4
26 Nov 18
Entry into a Material Definitive Agreement
8:55am
8-K
EX-10.2
qtp868
26 Nov 18
Entry into a Material Definitive Agreement
8:55am
8-K
EX-10.1
g8y75pdu
25 Jun 18
Departure of Directors or Certain Officers
6:24am
8-K
EX-10.1
nyv 61iqaf
22 May 18
DelMar Appoints Saiid Zarrabian to Full-Time President and CEO
6:14am